|
Insider Trading: Threshold Pharmaceuticals Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Threshold Pharmaceuticals Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Threshold Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Threshold Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is THLD.
The reporting company's CIK number is 1183765.
The total value of stock buying since 2005 is $15,926,295.
The total value of stock sales is $105,870,040.
The total value of stock exercises is $0.
1 year stock price chart,
1 day stock price chart
THLD 1 year chart THLD 1 day chart
Figure 1. Monthly insider transaction values at Threshold Pharmaceuticals Inc (THLD) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
12 01 2008 02 03 04 05 06 07 08 09 10 11 12 01 2009 02 03 04 05 06 07 08 09 10 11 -
Figure 2. Average prices of insider buys, sales, and option exercises at Threshold Pharmaceuticals Inc (THLD) in the past 24 months. See table 2 for insider transaction details.
12 01 2008 02 03 04 05 06 07 08 09 10 11 12 01 2009 02 03 04 05 06 07 08 09 10 11 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Threshold Pharmaceuticals Inc (THLD).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2009-11 | 5,000 | 14,150 | 0 | 0 | 0 | 0 |
| 2009-10 | 7,961,464 | 12,149,705 | 0 | 0 | 0 | 0 |
| 2009-09 | 5,000 | 7,650 | 0 | 0 | 0 | 0 |
| 2009-08 | 5,000 | 7,950 | 0 | 0 | 0 | 0 |
| 2009-07 | 5,000 | 7,500 | 0 | 0 | 0 | 0 |
| 2009-06 | 25,000 | 37,750 | 0 | 0 | 0 | 0 |
| 2009-03 | 5,000 | 5,350 | 0 | 0 | 0 | 0 |
| 2009-01 | 5,000 | 3,115 | 0 | 0 | 0 | 0 |
| 2008-10 | 5,000 | 2,240 | 0 | 0 | 0 | 0 |
| 2008-08 | 1,789,213 | 3,649,992 | 0 | 0 | 0 | 0 |
| 2008-07 | 5,000 | 1,950 | 0 | 0 | 0 | 0 |
| 2008-03 | 5,000 | 1,845 | 0 | 0 | 0 | 0 |
| 2008-01 | 5,000 | 2,090 | 0 | 0 | 0 | 0 |
| 2007-12 | 10,000 | 6,280 | 0 | 0 | 0 | 0 |
| 2007-11 | 8,784 | 4,968 | 0 | 0 | 0 | 0 |
| 2007-03 | 0 | 0 | 415,574 | 611,309 | 0 | 0 |
| 2007-02 | 0 | 0 | 750,000 | 1,135,500 | 0 | 0 |
| 2006-03 | 0 | 0 | 5,562,000 | 80,008,500 | 0 | 0 |
| 2005-10 | 0 | 0 | 204,404 | 2,114,731 | 0 | 0 |
| 2005-08 | 0 | 0 | 2,488,688 | 22,000,000 | 0 | 0 |
| 2005-03 | 4,000 | 23,760 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for Threshold Pharmaceuticals Inc (THLD)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2009-11-02 | Curd John G (President and CMO) | Purchase | 5,000 | 2.83 | 14,150 |
| 2009-10-05 | Curd John G (President and CMO) | Purchase | 26,178 | 1.86 | 48,691 |
| 2009-10-05 | Sweet David E (10% Owner) | Purchase | 9,497 | 1.91 | 18,139 |
| 2009-10-05 | Selick Harold E (Chief Executive Officer) | Purchase | 52,356 | 1.86 | 97,382 |
| 2009-10-05 | Bird Jeffrey W (Director) | Purchase | 1,178,431 | 1.91 | 2,250,802 |
| 2009-10-05 | Hurwitz Edward (Other) | Purchase | 261,780 | 1.91 | 499,999 |
| 2009-10-05 | Sheehan Andrew T (10% Owner) | Purchase | 1,156,890 | 1.91 | 2,209,658 |
| 2009-10-05 | White James N (10% Owner) | Purchase | 37,619 | 1.91 | 71,852 |
| 2009-10-05 | Sands Gregory P (10% Owner) | Purchase | 24,679 | 1.91 | 47,136 |
| 2009-10-05 | Younger William H Jr (10% Owner) | Purchase | 66,274 | 1.91 | 126,583 |
| 2009-10-05 | Baker G Leonard Jr (10% Owner) | Purchase | 40,566 | 1.91 | 77,481 |
| 2009-10-05 | Gaither James C (10% Owner) | Purchase | 17,472 | 1.91 | 33,371 |
| 2009-10-05 | Coxe Tench (10% Owner) | Purchase | 151,896 | 1.91 | 290,121 |
| 2009-10-05 | Jaeger Wilfred E (Director) | Purchase | 1,047,120 | 1.86 | 1,947,643 |
| 2009-10-05 | Werner Harold R (10% Owner) | Purchase | 1,570,680 | .00 | 0 |
| 2009-10-05 | Anderson David L (10% Owner) | Purchase | 27,558 | 1.91 | 52,635 |
| 2009-10-01 | Curd John G (President and CMO) | Purchase | 5,000 | 1.83 | 9,150 |
| 2009-09-01 | Curd John G (President and CMO) | Purchase | 5,000 | 1.53 | 7,650 |
| 2009-08-03 | Curd John G (President and CMO) | Purchase | 5,000 | 1.59 | 7,950 |
| 2009-07-01 | Curd John G (President and CMO) | Purchase | 5,000 | 1.50 | 7,500 |
| 2009-06-05 | Selick Harold E (Chief Executive Officer) | Purchase | 10,000 | 1.48 | 14,800 |
| 2009-06-03 | Curd John G (President and CMO) | Purchase | 5,000 | 1.49 | 7,450 |
| 2009-06-03 | Selick Harold E (Chief Executive Officer) | Purchase | 10,000 | 1.55 | 15,500 |
| 2009-03-03 | Curd John G (President and CMO) | Purchase | 5,000 | 1.07 | 5,350 |
| 2009-01-26 | Curd John G (President and CMO) | Purchase | 5,000 | .62 | 3,115 |
| 2008-10-29 | Curd John G (President and CMO) | Purchase | 5,000 | .45 | 2,240 |
| 2008-08-29 | Curd John G (President and CMO) | Purchase | 24,509 | 2.04 | 49,998 |
| 2008-08-29 | Selick Harold E (Chief Executive Officer) | Purchase | 49,019 | 2.04 | 99,998 |
| 2008-08-29 | Tang Capital Partners Lp (10% Owner) | Purchase | 735,294 | 2.04 | 1,499,999 |
| 2008-08-29 | Jaeger Wilfred E (Director) | Purchase | 980,391 | 2.04 | 1,999,997 |
| 2008-07-16 | Curd John G (President and CMO) | Purchase | 5,000 | .39 | 1,950 |
| 2008-03-20 | Curd John G (President and CMO) | Purchase | 5,000 | .37 | 1,845 |
| 2008-01-31 | Curd John G (President and CMO) | Purchase | 5,000 | .42 | 2,090 |
| 2007-12-14 | Curd John G (President and CMO) | Purchase | 5,000 | .65 | 3,240 |
| 2007-12-03 | Curd John G (President and CMO) | Purchase | 5,000 | .61 | 3,040 |
| 2007-11-29 | Selick Harold E (Chief Executive Officer) | Purchase | 3,484 | .56 | 1,951 |
| 2007-11-21 | Selick Harold E (Chief Executive Officer) | Purchase | 300 | .56 | 168 |
| 2007-11-16 | Curd John G (President and CMO) | Purchase | 5,000 | .57 | 2,849 |
| 2007-03-01 | Enright Patrick G (Director) | Sale | 415,574 | 1.47 | 611,309 |
| 2007-02-28 | Enright Patrick G (Director) | Sale | 750,000 | 1.51 | 1,135,500 |
| 2006-03-16 | Powell Michael (Director) | Sale | 2,562,000 | 14.25 | 36,508,500 |
| 2006-03-03 | Three Arch Associates Iii Lp (10% Owner) | Sale | 2,000,000 | 14.50 | 29,000,000 |
| 2005-10-28 | Christoffersen Ralph E (Director) | Sale | 37,037 | 9.83 | 364,073 |
| 2005-10-28 | Enright Patrick G (Other) | Sale | 57,003 | 10.46 | 596,251 |
| 2005-10-28 | Schreiber Alain (10% Owner) | Sale | 110,364 | 10.46 | 1,154,407 |
| 2005-08-25 | Christoffersen Ralph E (Director) | Sale | 1,244,344 | 8.84 | 11,000,000 |
| 2005-08-25 | Morgenthaler Partners Vii Lp (Director) | Sale | 1,244,344 | 8.84 | 11,000,000 |
| 2005-03-11 | Tidmarsh George F (Founder and Presiden) | Purchase | 4,000 | 5.94 | 23,760 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Threshold Pharmaceuticals Inc (symbol THLD,
CIK number 1183765) see
the Securities and Exchange Commission (SEC) website.
|
|
